Immune pathogenesis of multiple sclerosis

Neurological Sciences

Volumn 26, Issue SUPPL. 1, 2005, Pages

  Wekerle, H ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOPSY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DISEASE COURSE; ENCEPHALITIS; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBER DEGENERATION; NONHUMAN; NOTE; SENSORY DYSFUNCTION; T LYMPHOCYTE; WHITE MATTER;

AUTOIMMUNITY; HUMANS; MACROPHAGES; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 18344387563     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-005-0386-9     Document Type: Note

References (3)

1. Hohlfeld R, Wekerle H (2004) Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines. Proc Nat Acad Sci USA 101[Suppl 2]:14599-14606
2. Lassmann H, Brück W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: Implications for diagnosis and therapy. Trends Mol Med 7:115-121
3. Martin R, Sturzebecher CS, McFarland HF (2001) Immunotherapy of multiple sclerosis: Where are we? Where should we go? Nature Immunol 2:785-788